Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | FABP7 | O15540 | 2/20 | 0.46 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 2/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447213 | 1.00 | KMT2A (0.66) | KMT2AEPHX2FABP7FABP5CA1 | |
| Bromide SCHEMBL2216954 | 0.99 | KMT2A (0.64) | KMT2AEPHX2FABP7FABP5CA1 | |
| Hydrochloric Acid SCHEMBL29599906 | 0.99 | KMT2A (0.64) | KMT2AEPHX2FABP7FABP5CA1 | |
| Hydrochloric Acid SCHEMBL966018 | 0.99 | KMT2A (0.64) | KMT2AEPHX2FABP7FABP5CA1 | |
| Phosphoric Acid SCHEMBL22468200 | 0.95 | KMT2A (0.60) | KMT2AEPHX2FABP7FABP5CA1 | |
| SCHEMBL21526565 | 0.95 | KMT2A (0.60) | KMT2AEPHX2FABP7FABP5CA1 | |
| SCHEMBL1901192 | 0.92 | KMT2A (0.70) | KMT2AEPHX2FABP7FABP5CA1 | |
| Trifluoroacetic Acid SCHEMBL5553311 | 0.91 | KMT2A (0.60) | KMT2AEPHX2FABP7FABP5CASP3 | |
| SCHEMBL31135496 | 0.90 | KMT2A (0.73) | KMT2AEPHX2FABP7FABP5CA1 | |
| Bromide SCHEMBL15809739 | 0.90 | KMT2A (0.69) | KMT2AEPHX2FABP7FABP5CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118304441-B | Tumor-targeted fluorescent probe and preparation method and application thereof | 江苏省人民医院（南京医科大学第一附属医院） | 2025-03-18 | — | — | CN | claimed |
| CN-118924682-A | Difunctional dendritic lipopeptide nano micelle and preparation method and application thereof | 中国药科大学 | 2024-11-12 | — | — | CN | claimed |
| WO-2024221952-A1 | NANO-DELIVERY SYSTEM OF NUCLEOTIDE DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-10-31 | — | — | WO | claimed |
| CN-118831053-A | Nanometer delivery system of nucleotide drug and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-10-25 | — | — | CN | claimed |
| CN-118304441-A | Tumor-targeted fluorescent probe and preparation method and application thereof | 江苏省人民医院（南京医科大学第一附属医院） | 2024-07-09 | — | — | CN | claimed |
| US-7226636-B2 | Suspension of magnetic particles in liquid; adding a gold compound; mixing with reducing agents | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2007-06-05 | — | — | US | claimed |
| US-20050025969-A1 | Suspension of magnetic particles in liquid; adding a gold compound; mixing with reducing agents | LOS ALAMOS NATIONAL SECURITY, LLC | 2005-02-03 | — | — | US | claimed |
| EP-4692105-A1 | CYCLIC POLYPEPTIDE COMPOUND AND USE THEREOF | Bivision Pharmaceuticals, Inc (CN) | 2026-02-11 | — | — | EP | disclosed |
| US-20260007756-A1 | COMPOUND AND USE THEREOF | COHERENT BIOPHARMA SUZHOU LTD (CN) | 2026-01-08 | — | — | US | disclosed |
| EP-4663205-A1 | POLYMER-DRUG CONJUGATE, INTERMEDIATE THEREOF, AND USE THEREOF | Shanghai Best-Link Bioscience, LLC (CN) | 2025-12-17 | — | — | EP | disclosed |
| EP-4658315-A1 | POLYMER-DRUG CONJUGATES | Primelink Biotherapeutics (Shenzhen) Co., Ltd. (CN) | 2025-12-10 | — | — | EP | disclosed |
| US-12403199-B2 | Asymmetrically branched degradable polyethylene glycol derivative | NOF CORPORATION (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-114901315-B | Fibroblast Activation Protein (FAP) -targeted imaging and treatment of cancer and other fibrotic and inflammatory diseases | 普渡研究基金会 | 2025-04-29 | — | — | CN | disclosed |
| WO-2004037772-A1 | CONVENIENT AND SCALABLE SYNTHESIS OF ETHYL N-[(2-BOC-AMINO) ETHYL] GLYCINATE AND ITS HYDROCHLORIDE SALT | THE UNIVERSITY OF WESTERN ONTARIO (CA) | 2004-05-06 | — | — | WO | disclosed |
| WO-2003055852-A2 | MULTIFUNCTIONAL REAGENT FOR THE SYNTHESIS OF THIOL MODIFIED OLIGOMERS | FRIZ BIOCHEM GMBH (DE) | 2003-07-10 | — | — | WO | disclosed |
| US-6518242-B1 | Derivatives of glycopeptide antibacterial agents | THERAVANCE, INC. | 2003-02-11 | — | — | US | disclosed |
| EP-1060189-A1 | DERIVATIVES OF GLYCOPEPTIDE ANTIBACTERIAL AGENTS | Advanced Medicine, Inc. (US) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999042476-A1 | NOVEL ANTIBACTERIAL AGENTS | ADVANCED MEDICINE, INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| EP-0705279-A4 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 1999-03-24 | — | — | EP | disclosed |
| EP-0705279-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1996-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12403199-B2 | Asymmetrically branched degradable polyethylene glycol derivative | MAN2B1, MGLL, PKLR | KMT2A 3557/4885EPHX2 1272/4885FABP7 2803/4885 |
| US-20260007756-A1 | COMPOUND AND USE THEREOF | FOLH1, TRPV6, FOLR1 | KMT2A 2977/4885EPHX2 2742/4885FABP7 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.